Pharmacological management of osteoporosis and concomitant calcium supplementation in a Portuguese urban population: The EpiPorto study (2005-2007)

Clinical and Experimental Rheumatology

Volumn 27, Issue 1, 2009, Pages 47-53

  Lucas, Raquel ^a   Rocha, Olavo ^a   Bastos, Joana ^a   Costa, Lúcia ^b   Barros, Henrique ^a   Lunet, Nuno ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b Department of Rheumatology   (Portugal)

Author keywords

General population; Guideline; Health survey; Osteoporosis; Therapeutics

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; RALOXIFENE;

ADULT; AGED; ARTICLE; BLUE COLLAR WORKER; CALCIUM INTAKE; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL CARE; OCCUPATION; OSTEOPOROSIS; POPULATION RISK; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE;

AGED; BONE DENSITY CONSERVATION AGENTS; CALCIUM, DIETARY; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PORTUGAL;

EID: 63049130986     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. POOLE KE, COMPSTON JE: Osteoporosis and its management. Br Med J 2006; 333: 1251-6.
2. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001 Feb 14; 295: 785-95.
3. BROWN JP, JOSSE RG: 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J 2002; 167: S1-34.
4. TAVARES V, CANHAO H, GOMES JA et al.: Recommendations for the diagnosis and management of osteoporosis. Acta Reumatol Port 2007; 32: 49-59.
5. SHEA B, WELLS G, CRANNEY A et al.: Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of post-menopausal osteoporosis. Endocr Rev 2002: 23: 552-9.
6. ROCHA O, LUNET N, COSTA L et al.: Osteoporosis treatment in Portugal: Trends and geographical variation. Acta Med Port 2006; 19: 373-80.
7. WARRINER A, CURTIS JR, SAAG KG: Challenges in defining and improving osteoporosis quality of care. Clin Exp Rheumatol 2007; 25: 142-6.
8. WATSON J, WISE L, GREEN J: Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol 2007; 63: 843-9.
9. ANDRADE SE, MAJUMDAR SR, CHAN KA et al.: Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003; 163: 2052-7.
10. PETRELLA RJ, JONES TJ: Do patients receive recommended treatment of osteoporosis following hip fracture in primary care? BMC Fam Pract 2006; 7: 31.
11. RAMOS E, LOPES C, BARROS H: Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann Epidemiol 2004; 14: 437-41.
12. SANTOS AC, BARROS H: Prevalence and determinants of obesity in an urban sample of Portuguese adults. Public Health 2003; 117: 430-7.
13. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2007 (cited 10th December 2007); Available from: Http://www.whocc.no/ atcddd/
14. INSTITUTO DO EMPREGO E DA FORMAÇÃO PROFISSIONAL: Classificação Nacional de Profissões,. (cited 19 November 2007); Available from: Http://portal.iefp.pt/pls/ gov_portal_iefp/docs/PAGE/PORTAL_IEFP_INTERNET/CPROFISSONAL/CNP/ INDICE.PDF
15. WILLETT W: Food frequency methods. In WILLETT WC (Eds.) Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press 1998: 74-100.
16. LOPES C, ARO A, AZEVEDO A et al.: Intake and adipose tissue composition of fatty acids and risk of myocardial infarction in a male Portuguese community sample. J Am Diet Assoc 2007; 107: 276-86.
17. KLUNGEL OIL DE BOER A, PAES AH et al.: Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol 2000; 53: 273-7.
18. KOTHAWALA P, BADAMGARAV E, RYU S et al.: Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 2007; 82: 1493-501.
19. CARR AJ, THOMPSON PW, COOPER C: Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: A cross-sectional survey. Osteoporos Int 2006; 17: 1638-44.
20. GRAMPP S, GENANT HK, MATHUR A et al.: Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res 1997; 12: 697-711.
21. BAYLY JR, HOLLANDS RD, RIORDAN-JONES SE et al.: Prescribed vitamin D and calcium preparations in patients treated with bone re-modelling agents in primary care: A report of a pilot study. Curr Med Res Opin 2006; 22: 131-7.
22. CADARETTE SM, GIGNAC MA, JAGLAL SB et al.: Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing. Med Care 2007; 45: 896-901.
23. HAMEL ME, SEBALDT RJ, SIMINOSKI K et al.: Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two nork-academic community centers. Osteoporos Int 2005; 16: 208-15.
24. FELDSTEIN AC, NICHOLS G, ORWOLL E et al.: The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int 2005; 16: 953-62.
25. PAPAIOANNOU A, KENNEDY CC, IOANNIDIS G et al.: The osteoporosis care gap in men with fragility fractures: The Canadian Multicentre Osteoporosis Study. Osteoporos Int 2008; 19: 581-7.
26. PERREAULT S, DRAGOMIR A, DESGAGNE A et al.: Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiol Drug Saf 2005; 14: 685-95.
27. CHENOT R, SCHEIDT-NAVE C, GABLER S et al.: German primary care doctors' awareness of osteoporosis and knowledge of national guidelines. Exp Clin Endocrinol Diabetes 2007; 115: 584-9.
28. TANG BM, ESLICK GD, NOWSON C et al.: Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis. Lancet 2007; 370: 657-66.
29. PRINCE RL, DEVINE A, DHALIWAL SS et al.: Effects of calcium supplementation on clinical fracture and bone structure: Results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 2006; 166: 869-75.